Other
German biotech company MorphoSys buys US rival for $1.7B
Germany-based MorphoSys AG said Wednesday that it is buying U.S. rival Constellation Pharmaceuticals Inc. in a deal valuing the biotech company at $1.7 billion.
Jun 2, 2021
0
0
News tagged with constellation
Neuroscience
If you can't beat them, join them: Grandmother cells revisited
(Medical Xpress)—In the absence of any real progress in defining neuronal codes for the brain, the simple idea of the grandmother cell continues to percolate through the scientific and popular literature. Many researchers ...
Pediatrics
Obesity and metabolic syndrome associated with impaired brain function in adolescents
A new study by researchers at NYU School of Medicine reveals for the first time that metabolic syndrome (MetS) is associated with cognitive and brain impairments in adolescents and calls for pediatricians to take this into ...
Sep 3, 2012
0
0
Oncology & Cancer
Faulty proteins may prove significant in identifying new treatments for ovarian cancer
A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range ...
Jan 13, 2012
0
0
Oncology & Cancer
The concept of 'overactive bladder' serves better commercial rather than patient interests
"The overactive bladder syndrome has become an accepted way to simplify a complex array of symptoms and leads people to believe that an overactive bladder is an independent disease in itself. However, the truth is not as ...
Jan 13, 2012
1
0
Genetics
Genes linked to schizophrenia, bipolar disorder
Broad sweeps of the human genome have exposed genetic mutations that boost the risk of the devastating yet baffling diseases of schizophrenia and bipolar disorder, according to two studies published Sunday.
Sep 18, 2011
0
0
